Nykode Therapeutics ASA
NYKD | OL
Overview
Corporate Details
- ISIN(s):
- NO0010714785
- LEI:
- 254900UKQHWYZJD22017
- Country:
- Norway
- Address:
- Gaustadalleen 21, 0349 Oslo
- Website:
- https://nykode.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Nykode Therapeutics is a leading clinical-stage biopharmaceutical company. With our intelligent modular platform and tailored hyper-targeting, we’re unlocking unlimited possibilities for the future of medicine. With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-09 18:15 |
Director's Dealing
Nykode Therapeutics – Grant of Share Options - Attachment: Attachment 250709.pdf
|
English | 213.3 KB | |
| 2025-07-09 18:15 |
Remuneration Information
Nykode Therapeutics – Grant of Share Options
|
English | 1.1 KB | |
| 2025-07-04 16:41 |
Report Publication Announcement
Financial calendar
|
English | 508 bytes | |
| 2025-05-28 07:00 |
Quarterly Report
Nykode Therapeutics - Quarterly report Q1 2025 - Attachment: 250528 Nykode Quar…
|
English | 4.3 MB | |
| 2025-05-28 07:00 |
Report Publication Announcement
Nykode Therapeutics - Quarterly report Q1 2025
|
English | 3.0 KB | |
| 2025-05-27 07:00 |
Notice of Dividend Amount
Nykode Therapeutics ASA - Ex-dividend NOK 1.00 today
|
English | 490 bytes | |
| 2025-05-26 16:51 |
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation - A…
|
English | 125.5 KB | |
| 2025-05-26 16:51 |
Report Publication Announcement
Nykode Therapeutics – invitation to Q1 2025 financial results presentation
|
English | 3.2 KB | |
| 2025-05-26 11:25 |
Post-Annual General Meeting Information
Nykode Therapeutics ASA - Minutes of Annual General Meeting - Attachment: 25052…
|
English | 297.9 KB | |
| 2025-05-26 11:25 |
Post-Annual General Meeting Information
Nykode Therapeutics ASA - Minutes of Annual General Meeting
|
English | 2.8 KB | |
| 2025-05-23 05:00 |
Investor Presentation
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025…
|
English | 176.1 KB | |
| 2025-05-23 05:00 |
Regulatory News Service
Nykode Therapeutics Highlights New Data in Two Poster Presentations at the 2025…
|
English | 6.4 KB | |
| 2025-05-05 06:30 |
Pre-Annual General Meeting Information
Nykode Therapeutics ASA - Notice of Annual General Meeting
|
Norwegian | 319.2 KB | |
| 2025-05-05 06:30 |
Pre-Annual General Meeting Information
Nykode Therapeutics ASA - Notice of Annual General Meeting
|
English | 1.0 KB | |
| 2025-04-29 05:00 |
Annual Report (ESEF)
Nykode Therapeutics - Annual Report 2024
|
English | 17.1 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |